A review of current progress in triple-negative breast cancer therapy.

Open Med (Wars) · 2020 · PMC7718625 · PMID 33336070

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

An interim analysis of overall survival suggested a positive trend favoring talazoparib although these data are preliminary.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.